[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pain-cervical\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pain-cervical":74},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100615277",false,"NCT07290517","Assessing Pain and Effectiveness of Carevix Device for IUD Insertions","The Carevix Device: Assessing Pain and Effectiveness of a Suction-based Cervical Stabilizer for IUD Insertions in the Clinic Setting: a Randomized, Controlled Trial (CARE)","CARE","Inclusion Criteria (to be assessed prior to procedure):\n\n* Age 18 years or older\n* Able to consent on their own\n* Scheduled and will undergo an IUD insertion within 90 days of consent\n* Planned use of cervical stabilization device for placement\n* Procedure being performed by a trained provider\n* Provider is willing to use Carevix™ for scheduled procedure\n\nExclusion Criteria (to be assessed by provider at time of procedure):\n\n* Vaginal bleeding of unknown origin\n* Cervix less than 26 mm in diameter\n* Nabothian cyst on anterior lip of cervix\n* Cervical myomas\n* Cervical abnormalities\u002Fshape\n* Pregnant\n* Participants who are not fluent in and\u002For do not fully understand, read, write, or speak the English language\n* Other inability to provide informed consent to participate\n* Initial attempt to place the IUD without any cervical stabilization","FEMALE","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between IUD insertions using a suction cervical stabilizer (new device, FDA approved, atraumatic) and single-tooth tenaculum (standard, traumatic). Our aims are to:\n\n* assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum.\n* assess predictors of pain scores including between nulliparous and multiparous patients\n* assess provider-reported ease of use and satisfaction\n\nParticipants (including providers) will:\n\n* be randomized to receive one device to complete the IUD procedure\n* complete a survey following the procedure",[26,27,28],"IUD","Abnormal Uterine Bleeding","Pain, Cervical",[30,31,32,33],"IUD insertion","Cervical Stabilization","Tenaculum","Pain","NOT_YET_RECRUITING","2026-01-12",{"date":37,"type":38},"2026-01-14","ACTUAL",{"date":40,"type":20},"2026-02",{"date":42,"type":20},"2027-02",{"name":44,"class":45},"Indiana University","OTHER",1,{"id":48,"slug":4,"hasResults":10,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":10,"sex":54,"minAge":17,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":21,"phases":58,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":5},"100513739","NCT05969392","Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain","Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain : a Interventional, Prospective, Multi-center, Open-label Study.","DISCOCERV","Inclusion Criteria:\n\n* Patient 18 years or older;\n* Pain refractory to conservative treatments for more than 2 months, non-surgical patients\n* Cervicobrachialgia due to disc herniation\n* Chronic discogenic pain (1 or 2 cervical discs) with concordant MRI;\n* Patient agreeing to participate in the study and having given written consent;\n* Patient enrolled in a health insurance plan.\n\nExclusion Criteria:\n\n* Prior surgical treatment of the disc(s) studied;\n* Sick leave of more than 12 months secondary to painful symptoms;\n* Patient with Modic 1 score or more\n* History of cognitive-behavioral disorders that could affect the completion of self-questionnaires;\n* Local or systemic infection, or suspicion of infection;\n* Severe coagulation disorders;\n* Other inflammatory rheumatic disease;\n* Severe underlying pathology with life expectancy \\\u003C1 year;\n* Women of childbearing age who are pregnant at the inclusion visit or who wish to become pregnant before the administration of the treatment (V0);\n* Known allergy to contrast material and\u002For local anesthetic substances;\n* Patients who cannot read or write Italian;\n* Major person benefiting from a legal protection regime (guardianship, curatorship, safeguard of justice);","ALL","120 Years",{"count":57,"type":20},60,[59,60],"PHASE2","PHASE3","The purpose of this study is to assesse safety and efficacy of the Intradiscal Gelified Ethanol for treatment in refractory cervical discogenic pain.",[28,63],"Discogenic Pain","2025-03-07",{"date":66,"type":38},"2025-03-11",{"date":68,"type":20},"2025-04",{"date":70,"type":20},"2026-04",{"name":72,"class":73},"Gelscom SAS","INDUSTRY",""]